Find in Library

Background  Cervical cancer is the major urogenital cancer among women in India. This audit is done to analyze the treatment protocol at the tertiary cancer centre and identify the scope for improvement in this protocol.  Methods  This audit is the retrospective analysis of the reports of 500 cervical cancer patients. The data from the reports, such as the treatment given, diagnosis, prognosis, toxicities, and survival rates, were critically analyzed and subjected to statistical analysis.  Results 167 patients received only radiation therapy. The majority of the patients (333) received radiation as well as chemotherapy. 162 patients were given cisplatin every week. 98 patients were given carboplatin every week. Most of the patients, 486 out of 500, received brachytherapy; 14 of them didn’t receive brachytherapy due to metastasis of the cancer. 337 patients underwent treatment for more than 8 weeks, and 163 patients received treatment for less than 8 weeks. The survival rates were better in patients with both radiation therapy and chemotherapy, particularly in patients with cisplatin.  Conclusion  The factors contributing to the overall survival rate of cervical cancer patients chemoradiotherapy and brachytherapy were determined in this study.  Recommendation  To improve the overall survival rate, a protocol for regular follow-up and documentation of the detailed clinical profile of cervical cancer patients is required.